Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations is a research paper published in New England Journal of Medicine (2023). On theSindex it has a DataRank of 0.846. It has been cited 281 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.846
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →The Brain Tumour Charity
Grant: GN-000707
The Brain Tumour Charity
Grant: GN-000382
Novartis Pharmaceuticals Corporation
MeSH Terms